Literature DB >> 2346739

Long-term cyclosporin therapy may decrease the risk of chronic graft-versus-host disease.

B Lönnqvist, J Aschan, P Ljungman, O Ringdén.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2346739     DOI： 10.1111/j.1365-2141.1990.tb06356.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  5 in total

1.  Prolonged sirolimus administration after allogeneic hematopoietic cell transplantation is associated with decreased risk for moderate-severe chronic graft-versus-host disease.

Authors:  Joseph Pidala; Jongphil Kim; Melissa Alsina; Ernesto Ayala; Brian C Betts; Hugo F Fernandez; Teresa Field; Heather Jim; Mohamed A Kharfan-Dabaja; Frederick L Locke; Asmita Mishra; Taiga Nishihori; Leonel Ochoa-Bayona; Lia Perez; Marcie Riches; Claudio Anasetti
Journal:  Haematologica       Date:  2015-04-03       Impact factor: 9.941

2.  Variation in management of immune suppression after allogeneic hematopoietic cell transplantation.

Authors:  Joseph Pidala; Stephanie J Lee; Gwen Quinn; Heather Jim; Jongphil Kim; Claudio Anasetti
Journal:  Biol Blood Marrow Transplant       Date:  2011-04-11       Impact factor: 5.742

Review 3.  Bone marrow transplantation using unrelated donors for haematological malignancies.

Authors:  O Ringdén
Journal:  Med Oncol       Date:  1997-03       Impact factor: 3.064

4.  A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation.

Authors:  Johan Törlén; Olle Ringdén; Karin Garming-Legert; Per Ljungman; Jacek Winiarski; Kari Remes; Maija Itälä-Remes; Mats Remberger; Jonas Mattsson
Journal:  Haematologica       Date:  2016-08-04       Impact factor: 9.941

5.  Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence.

Authors:  Sally Arai; Bita Sahaf; Balasubramanian Narasimhan; George L Chen; Carol D Jones; Robert Lowsky; Judith A Shizuru; Laura J Johnston; Ginna G Laport; Wen-Kai Weng; Jonathan E Benjamin; Joanna Schaenman; Janice Brown; Jessica Ramirez; James L Zehnder; Robert S Negrin; David B Miklos
Journal:  Blood       Date:  2012-05-04       Impact factor: 22.113
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.